Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery

Thrombosis Research

Volumn 97, Issue 6, 2000, Pages 379-386

  Wahba, Alexander ^a   Rothe, Gregor ^b   Lodes, Heiko ^a   Barlage, Stefan ^b   Schmitz, Gerd ^b   Birnbaum, Dietrich E ^a  

^a Thoracic and Vascular Surgery ^*  (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Extracorporeal circulation; Flow cytometry; Heart surgery; Heparin effects; Platelet function

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HEPARIN; PADGEM PROTEIN; PROTAMINE; THROMBOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART SURGERY; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; AGED; ANTICOAGULANTS; BLOOD PLATELETS; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; FLOW CYTOMETRY; HEPARIN; HUMANS; IMMUNOPHENOTYPING; MIDDLE AGED; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034004339     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00181-4     Document Type: Article

References (22)

1. Woodman R.C., Harker L.A. Bleeding complications associated with cardiopulmonary bypass. Blood. 76:1990;1680-1697.
2. Kestin A.S., Shukri C.R., Loscalzo J., Ellis P.A., MacGregor H., Birjiniuk V., Quimet H., Pasche B., Nelson M.J., Benoit S.E., Rodino L.J., Barnard M.R., Michelson A.D. The platelet function defect of cardiopulmonary bypass. Blood. 82:1993;107-117.
3. Khuri S.F., Valeri C.R., Loscalzo J., Weinstein M.J., Birjiniuk V., Healey N.A., MacGregor H., Doursounian M., Zolkewitz M.A. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 60:1995;1008-1014.
4. John L.C.H., Rees G.M., Kovacs I.B. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage. J Thorac Cardiovasc Surg. 105:1993;816-822.
5. Valeri C.R., Khabbaz K., Khuri S.F., Marquardt C., Ragno G., Feingold H., Gray A.D., Axford T. Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg. 104:1992;108-116.
6. Wahba A., Black G., Koksch M., Rothe G., Preuner J., Schmitz G., Birnbaum D.E. Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens. Eur J Cardiothorac Surg. 10:1996;768-773.
7. Wenger R.K., Lukasiewicz H., Mikuta B.S., Niewjarowski S., Edmunds L.H. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg. 97:1989;235-239.
8. Rinder C.S., Bohnert J., Rinder H.M., Mitchell J., Ault K., Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology. 75:1991;388-393.
9. Wahba A., Black G., Koksch M., Rothe G., Preuner J., Schmitz G., Birnbaum D.E. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost. 75:1996;844-848.
10. Janes S.L., Wilson D.J., Cox A.D., Chronos N.A., Goodall A.H. ADP causes partial degranulation of platelets in the absence of aggregation. Br J Haematol. 86:1994;568-573.
11. Michelson A.D., Benoit S.E., Kroll M.H., Li J.M., Rohrer M.J., Kestin A.S., Barnard M.R. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible. Blood. 83:1994;3562-3573.
12. Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 332:1995;1553-1559.
13. Addo J.B., Bray P.F., Grigoryev D., Faraday N., Goldschmidt-Clermont P.J. Surface recruitment but not activation of integrin alpha IIb beta 3 (GPIIb-IIIa) requires a functional actin cytoskeleton. Arterioscler Thromb Vasc Biol. 15:1995;1466-1473.
14. Michelson A.D. Flow cytometry. A clinical test of platelet function Blood. 87:1996;4925-4936.
15. Koksch M., Rothe G., Kiefel V., Schmitz G. Fluorescence resonance energy transfer as a new method for the epitope-specific characterization of anti-platelet antibodies. J Immunol Methods. 187:1995;53-67.
16. Harker L.A., Malpass T.W., Branson H.E., Hessel E.A. II, Slichter S.J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass. acquired transient platelet dysfunction associated with selective α-granule release Blood. 56:1980;824-834.
17. Dechavanne M., Ffrench M., Pages J., Ffrench P., Boukerche H., Bryon P.A., McGregor J.L. Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost. 57:1987;106-109.
18. George J.N., Pickett E.B., Saucerman S., McEver R.P., Kunickl T.J., Kieffer N., Newman P.J. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observation in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 78:1986;340-348.
19. Wenger R.K., Lukasiewicz H., Mikuta B.S., Niewjarowski S., Edmunds L.H. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg. 97:1989;235-239.
20. Zilla P., Fasol R., Groscurth P., Klepetko W., Reichenspurner H., Wolner E. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg. 97:1989;379-388.
21. Noris P., Bertolino G., Previtali M., Ferrario M., Balduini C.L. Heparin infusion facilitates ex vivo spontaneous platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. Haemostasis. 23:1993;185-191.
22. Paolini R., Casonato A., Boeri G., Luzzatto G., Girolami A., Sasahara A.A., Cella G. Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation. J Med. 24:1993;113-130.